Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,594.90 INR | -1.29% |
|
-2.79% | -15.16% |
11/07 | Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Flat for Week | MT |
11/07 | Infosys enters stipulation and consent order with Vermont DFR | RE |
Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 15.35 | 15.45 | 15.49 | 15.05 | 15.06 | |||||
Return on Total Capital | 20.24 | 21.39 | 22.83 | 21.94 | 21.45 | |||||
Return On Equity % | 27.32 | 28.96 | 31.04 | 31.96 | 28.93 | |||||
Return on Common Equity | 27.38 | 29.07 | 31.19 | 32.1 | 29.02 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 33.98 | 31.91 | 29.58 | 29.45 | 29.82 | |||||
SG&A Margin | 9.45 | 8.89 | 8.57 | 8.79 | 8.61 | |||||
EBITDA Margin % | 27.15 | 25.23 | 23.08 | 22.66 | 23.12 | |||||
EBITA Margin % | 24.99 | 23.02 | 21.32 | 20.91 | 21.67 | |||||
EBIT Margin % | 24.53 | 23.02 | 21.01 | 20.66 | 21.21 | |||||
Income From Continuing Operations Margin % | 19.34 | 18.2 | 16.38 | 17.07 | 16.4 | |||||
Net Income Margin % | 19.27 | 18.17 | 16.37 | 17.06 | 16.38 | |||||
Net Avail. For Common Margin % | 19.27 | 18.17 | 16.37 | 17.06 | 16.38 | |||||
Normalized Net Income Margin | 16.41 | 15.34 | 14.09 | 14.54 | 14.34 | |||||
Levered Free Cash Flow Margin | 16.79 | 16.21 | 12.71 | 7.76 | 18.66 | |||||
Unlevered Free Cash Flow Margin | 16.91 | 16.31 | 12.83 | 7.95 | 18.82 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1 | 1.07 | 1.18 | 1.17 | 1.14 | |||||
Fixed Assets Turnover | 5.45 | 6.59 | 7.37 | 7.67 | 8.46 | |||||
Receivables Turnover (Average Receivables) | 3.85 | 3.98 | 3.84 | 3.67 | 3.67 | |||||
Inventory Turnover (Average Inventory) | 471.21 | 504.82 | 513 | 385.18 | 297.32 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.55 | 2 | 1.81 | 2.31 | 2.27 | |||||
Quick Ratio | 2.28 | 1.75 | 1.54 | 2 | 2 | |||||
Operating Cash Flow to Current Liabilities | 1 | 0.75 | 0.6 | 0.68 | 0.87 | |||||
Days Sales Outstanding (Average Receivables) | 94.92 | 91.64 | 94.98 | 99.63 | 99.57 | |||||
Days Outstanding Inventory (Average Inventory) | 0.77 | 0.72 | 0.71 | 0.95 | 1.23 | |||||
Average Days Payable Outstanding | 15.06 | 14.9 | 14.44 | 13.17 | 12.96 | |||||
Cash Conversion Cycle (Average Days) | 80.63 | 77.46 | 81.25 | 87.41 | 87.84 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 6.93 | 7.22 | 10.95 | 9.45 | 8.55 | |||||
Total Debt / Total Capital | 6.48 | 6.74 | 9.87 | 8.63 | 7.87 | |||||
LT Debt/Equity | 5.97 | 6.07 | 9.31 | 7.23 | 6 | |||||
Long-Term Debt / Total Capital | 5.58 | 5.66 | 8.39 | 6.61 | 5.52 | |||||
Total Liabilities / Total Assets | 29.16 | 35.75 | 39.76 | 35.82 | 35.39 | |||||
EBIT / Interest Expense | 127.96 | 139.07 | 109.31 | 68.46 | 83.44 | |||||
EBITDA / Interest Expense | 144.92 | 156.33 | 124.29 | 78.55 | 95.05 | |||||
(EBITDA - Capex) / Interest Expense | 133.96 | 145.59 | 115.17 | 73.8 | 89.68 | |||||
Total Debt / EBITDA | 0.19 | 0.17 | 0.23 | 0.23 | 0.21 | |||||
Net Debt / EBITDA | -0.79 | -0.58 | -0.3 | -0.53 | -0.72 | |||||
Total Debt / (EBITDA - Capex) | 0.21 | 0.18 | 0.25 | 0.24 | 0.22 | |||||
Net Debt / (EBITDA - Capex) | -0.85 | -0.63 | -0.33 | -0.56 | -0.76 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 6.11 | 20.28 | 11.65 | 1.92 | 3.85 | |||||
Gross Profit, 1 Yr. Growth % | 13.02 | 12.96 | 3.5 | 1.47 | 5.18 | |||||
EBITDA, 1 Yr. Growth % | 20.6 | 8.6 | 2.11 | 0.07 | 5.93 | |||||
EBITA, 1 Yr. Growth % | 22.48 | 9.32 | 1.76 | -0.03 | 7.58 | |||||
EBIT, 1 Yr. Growth % | 22.14 | 9.32 | 1.89 | 0.21 | 6.61 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 12.19 | 13.15 | 0.51 | 6.24 | -0.22 | |||||
Net Income, 1 Yr. Growth % | 12.1 | 13.39 | 0.61 | 6.24 | -0.28 | |||||
Normalized Net Income, 1 Yr. Growth % | 16.69 | 9.13 | 2.52 | 5.21 | 2.65 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 11.42 | 14.75 | 1.43 | 7.04 | 0 | |||||
Accounts Receivable, 1 Yr. Growth % | 8.42 | 23.22 | 9.6 | 3.96 | 0.86 | |||||
Inventory, 1 Yr. Growth % | 0 | 31.58 | 0 | 72 | 11.63 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.34 | -3.57 | 3.58 | -7.67 | -3.79 | |||||
Total Assets, 1 Yr. Growth % | 20.92 | 4.92 | -1.56 | 7.91 | 5.42 | |||||
Tangible Book Value, 1 Yr. Growth % | 21.19 | -4.59 | -9.24 | 17.83 | 1.92 | |||||
Common Equity, 1 Yr. Growth % | 20.77 | -4.8 | -7.74 | 15.12 | 6.12 | |||||
Cash From Operations, 1 Yr. Growth % | 24.78 | 2.67 | -14.71 | 10.34 | 38.21 | |||||
Capital Expenditures, 1 Yr. Growth % | -38.71 | 1.75 | 10 | -16.61 | -1.13 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 66.15 | 12.77 | -12.47 | -37.77 | 149.69 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 65.53 | 12.71 | -12.2 | -36.85 | 145.84 | |||||
Dividend Per Share, 1 Yr. Growth % | 50 | 13.89 | 0 | 12.2 | 10.87 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 7.21 | 12.97 | 15.89 | 6.68 | 2.88 | |||||
Gross Profit, 2 Yr. CAGR % | 7.63 | 12.99 | 8.12 | 2.48 | 3.31 | |||||
EBITDA, 2 Yr. CAGR % | 11.08 | 16.11 | 5.31 | 1.09 | 2.97 | |||||
EBITA, 2 Yr. CAGR % | 12.1 | 16.49 | 6.32 | 0.86 | 3.68 | |||||
EBIT, 2 Yr. CAGR % | 11.07 | 17.41 | 5.54 | 1.05 | 3.37 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 9.19 | 12.67 | 6.64 | 3.33 | 2.96 | |||||
Net Income, 2 Yr. CAGR % | 9.01 | 12.74 | 6.81 | 3.39 | 2.93 | |||||
Normalized Net Income, 2 Yr. CAGR % | 7.48 | 14.54 | 5.77 | 3.86 | 3.82 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 9.81 | 13.08 | 7.89 | 4.2 | 3.46 | |||||
Accounts Receivable, 2 Yr. CAGR % | 12.07 | 15.59 | 16.22 | 6.73 | 3.24 | |||||
Inventory, 2 Yr. CAGR % | 8.97 | 14.71 | 14.71 | 31.15 | 38.56 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 15.3 | 0.31 | -0.06 | -2.21 | -5.75 | |||||
Total Assets, 2 Yr. CAGR % | 10 | 12.64 | 1.63 | 3.06 | 6.66 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.07 | 7.53 | -6.94 | 3.41 | 9.59 | |||||
Common Equity, 2 Yr. CAGR % | 5.45 | 7.23 | -6.28 | 3.06 | 10.53 | |||||
Cash From Operations, 2 Yr. CAGR % | 20.01 | 13.19 | -6.42 | -2.99 | 23.49 | |||||
Capital Expenditures, 2 Yr. CAGR % | -9.63 | -21.03 | 5.8 | -4.23 | -9.2 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 7.39 | 38.9 | -0.65 | -26.19 | 24.68 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 7.77 | 38.58 | -0.52 | -25.54 | 24.62 | |||||
Dividend Per Share, 2 Yr. CAGR % | 20 | 30.7 | 6.72 | 5.92 | 11.53 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 7.42 | 11.4 | 12.53 | 11.03 | 5.73 | |||||
Gross Profit, 3 Yr. CAGR % | 6.54 | 9.38 | 9.73 | 5.86 | 2.65 | |||||
EBITDA, 3 Yr. CAGR % | 7.84 | 11.32 | 11.24 | 3.53 | 2.68 | |||||
EBITA, 3 Yr. CAGR % | 8.11 | 11.66 | 11.96 | 4.16 | 3.05 | |||||
EBIT, 3 Yr. CAGR % | 7.76 | 11.66 | 11.99 | 3.73 | 2.88 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 1.8 | 10.5 | 8.46 | 6.51 | 2.13 | |||||
Net Income, 3 Yr. CAGR % | 1.67 | 10.45 | 8.54 | 6.62 | 2.15 | |||||
Normalized Net Income, 3 Yr. CAGR % | 4.48 | 9.11 | 10.39 | 5.59 | 3.38 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 3.51 | 11.44 | 9.05 | 7.6 | 2.78 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.18 | 15.67 | 13.56 | 11.97 | 5.31 | |||||
Inventory, 3 Yr. CAGR % | 1.82 | 16.04 | 9.58 | 31.29 | 24.29 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 11.28 | 7.95 | 1.39 | -2.66 | -2.74 | |||||
Total Assets, 3 Yr. CAGR % | 6.55 | 8.28 | 7.69 | 3.68 | 3.84 | |||||
Tangible Book Value, 3 Yr. CAGR % | -0.9 | 0.45 | 1.62 | 0.67 | 2.91 | |||||
Common Equity, 3 Yr. CAGR % | 1.59 | 1.92 | 1.99 | 0.37 | 4.07 | |||||
Cash From Operations, 3 Yr. CAGR % | 13.02 | 13.93 | 3 | -1.14 | 9.16 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.76 | -5.99 | -11.8 | -2.27 | -3.21 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 21.75 | 10.22 | 19.08 | -14.99 | 10.81 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 22.04 | 10.45 | 19.02 | -14.51 | 10.89 | |||||
Dividend Per Share, 3 Yr. CAGR % | 11.46 | 17.93 | 19.54 | 8.51 | 7.55 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.38 | 9.83 | 10.73 | 9.49 | 8.57 | |||||
Gross Profit, 5 Yr. CAGR % | 6.01 | 6.71 | 7.17 | 6.56 | 7.12 | |||||
EBITDA, 5 Yr. CAGR % | 7.06 | 8.28 | 7.44 | 7.11 | 7.86 | |||||
EBITA, 5 Yr. CAGR % | 6.91 | 8.14 | 7.68 | 7.56 | 8.59 | |||||
EBIT, 5 Yr. CAGR % | 6.73 | 8.3 | 7.55 | 7.29 | 8.46 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 5.03 | 6.76 | 3.71 | 7.57 | 6.22 | |||||
Net Income, 5 Yr. CAGR % | 4.95 | 6.72 | 3.7 | 7.57 | 6.26 | |||||
Normalized Net Income, 5 Yr. CAGR % | 4.35 | 6.26 | 5.63 | 6.98 | 7.71 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 6.33 | 8.38 | 5.24 | 8.48 | 6.78 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.11 | 12.92 | 13.17 | 12.01 | 9.31 | |||||
Inventory, 5 Yr. CAGR % | 2.25 | 4.56 | 6.79 | 21.86 | 20.36 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 10.07 | 6.09 | 6.19 | 3.77 | -1.53 | |||||
Total Assets, 5 Yr. CAGR % | 5.44 | 3.89 | 4.55 | 6.16 | 7.28 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1.62 | -2.22 | -3.36 | 1.63 | 4.74 | |||||
Common Equity, 5 Yr. CAGR % | 2.29 | -1.34 | -1.63 | 2.37 | 5.32 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.84 | 9.77 | 4.8 | 6.83 | 10.75 | |||||
Capital Expenditures, 5 Yr. CAGR % | -7.15 | -6.74 | 0.57 | -5.29 | -10.77 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.95 | 17.14 | 12.9 | -6.12 | 21.29 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 14.11 | 17.28 | 13.11 | -5.66 | 21.23 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14.24 | 14.32 | 9.54 | 12.97 | 16.27 |
- Stock Market
- Equities
- INFY Stock
- Financials Infosys Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition